220 related articles for article (PubMed ID: 34178724)
1. Targeting SUMOylation in
Sumam de Oliveira D; Kronenberger T; Palmisano G; Wrenger C; de Souza EE
Front Cell Infect Microbiol; 2021; 11():685866. PubMed ID: 34178724
[TBL] [Abstract][Full Text] [Related]
2. Identification of biochemically distinct properties of the small ubiquitin-related modifier (SUMO) conjugation pathway in Plasmodium falciparum.
Reiter K; Mukhopadhyay D; Zhang H; Boucher LE; Kumar N; Bosch J; Matunis MJ
J Biol Chem; 2013 Sep; 288(39):27724-36. PubMed ID: 23943616
[TBL] [Abstract][Full Text] [Related]
3. Inhibitors of ubiquitin E3 ligase as potential new antimalarial drug leads.
Jain J; Jain SK; Walker LA; Tekwani BL
BMC Pharmacol Toxicol; 2017 Jun; 18(1):40. PubMed ID: 28577368
[TBL] [Abstract][Full Text] [Related]
4. Detection of SUMOylation in Plasmodium falciparum.
Reiter KH; Matunis MJ
Methods Mol Biol; 2016; 1475():283-90. PubMed ID: 27631812
[TBL] [Abstract][Full Text] [Related]
5. Characterization and Structural Insights into Selective E1-E2 Interactions in the Human and Plasmodium falciparum SUMO Conjugation Systems.
Reiter KH; Ramachandran A; Xia X; Boucher LE; Bosch J; Matunis MJ
J Biol Chem; 2016 Feb; 291(8):3860-70. PubMed ID: 26697886
[TBL] [Abstract][Full Text] [Related]
6. Identification of a novel post-translational modification in Plasmodium falciparum: protein sumoylation in different cellular compartments.
Issar N; Roux E; Mattei D; Scherf A
Cell Microbiol; 2008 Oct; 10(10):1999-2011. PubMed ID: 18547337
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitin Proteasome System as a Potential Drug Target for Malaria.
Pereira PHS; Curra C; Garcia CRS
Curr Top Med Chem; 2018; 18(5):315-320. PubMed ID: 29701143
[TBL] [Abstract][Full Text] [Related]
8. Backbone and side-chain resonance assignments of Plasmodium falciparum SUMO.
Singh JS; Shukla VK; Gujrati M; Mishra RK; Kumar A
Biomol NMR Assign; 2017 Apr; 11(1):17-20. PubMed ID: 27699617
[TBL] [Abstract][Full Text] [Related]
9. SUMO proteases as potential targets for cancer therapy.
Bialik P; Woźniak K
Postepy Hig Med Dosw (Online); 2017 Dec; 71(0):997-1004. PubMed ID: 29225200
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic regulation as a therapeutic target in the malaria parasite Plasmodium falciparum.
Reyser T; Paloque L; Augereau JM; Di Stefano L; Benoit-Vical F
Malar J; 2024 Feb; 23(1):44. PubMed ID: 38347549
[TBL] [Abstract][Full Text] [Related]
11. Identification of a new small ubiquitin-like modifier (SUMO)-interacting motif in the E3 ligase PIASy.
Kaur K; Park H; Pandey N; Azuma Y; De Guzman RN
J Biol Chem; 2017 Jun; 292(24):10230-10238. PubMed ID: 28455449
[TBL] [Abstract][Full Text] [Related]
12. In Vitro SUMOylation Assay to Study SUMO E3 Ligase Activity.
Yang WS; Campbell M; Kung HJ; Chang PC
J Vis Exp; 2018 Jan; (131):. PubMed ID: 29443041
[TBL] [Abstract][Full Text] [Related]
13. SUMOylation and DeSUMOylation: Prospective therapeutic targets in cancer.
Wu W; Huang C
Life Sci; 2023 Nov; 332():122085. PubMed ID: 37722589
[TBL] [Abstract][Full Text] [Related]
14. Manipulating Eryptosis of Human Red Blood Cells: A Novel Antimalarial Strategy?
Boulet C; Doerig CD; Carvalho TG
Front Cell Infect Microbiol; 2018; 8():419. PubMed ID: 30560094
[TBL] [Abstract][Full Text] [Related]
15. Sumoylation as a signal for polyubiquitylation and proteasomal degradation.
Miteva M; Keusekotten K; Hofmann K; Praefcke GJ; Dohmen RJ
Subcell Biochem; 2010; 54():195-214. PubMed ID: 21222284
[TBL] [Abstract][Full Text] [Related]
16. Biochemical characterization of SUMO-conjugating enzymes by in vitro sumoylation assays.
Eisenhardt N; Ilic D; Nagamalleswari E; Pichler A
Methods Enzymol; 2019; 618():167-185. PubMed ID: 30850051
[TBL] [Abstract][Full Text] [Related]
17. N-terminal α-amino SUMOylation of cofilin-1 is critical for its regulation of actin depolymerization.
Weng W; Gu X; Yang Y; Zhang Q; Deng Q; Zhou J; Cheng J; Zhu MX; Feng J; Huang O; Li Y
Nat Commun; 2023 Sep; 14(1):5688. PubMed ID: 37709794
[TBL] [Abstract][Full Text] [Related]
18. SUMOylation of ATF3 alters its transcriptional activity on regulation of TP53 gene.
Wang CM; Brennan VC; Gutierrez NM; Wang X; Wang L; Yang WH
J Cell Biochem; 2013 Mar; 114(3):589-98. PubMed ID: 22991139
[TBL] [Abstract][Full Text] [Related]
19. Control of SUMO and Ubiquitin by ROS: Signaling and disease implications.
Stankovic-Valentin N; Melchior F
Mol Aspects Med; 2018 Oct; 63():3-17. PubMed ID: 30059710
[TBL] [Abstract][Full Text] [Related]
20. SUMOylation of the transcription factor ZFHX3 at Lys-2806 requires SAE1, UBC9, and PIAS2 and enhances its stability and function in cell proliferation.
Wu R; Fang J; Liu M; A J; Liu J; Chen W; Li J; Ma G; Zhang Z; Zhang B; Fu L; Dong JT
J Biol Chem; 2020 May; 295(19):6741-6753. PubMed ID: 32249212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
